AnaptysBio Inc

ANABNASDAQ · USD
47.94USD0.00 (+5.53%)
657

AnaptysBio Inc (ANAB) Straddle

ANAB straddle scan found 30 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 60.6%.

Read more

Trading a ANAB straddle lets you take a pure volatility position on AnaptysBio Inc without committing to a direction. AnaptysBio Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ANAB straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ANAB profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when AnaptysBio Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ANAB straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation.

The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ANAB straddle is the cleanest expression of that view. Our scanner prices every ANAB straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ANAB straddle into a catalyst or short a ANAB straddle to harvest decay, the options straddle setups that matter are all in one place.

May 21, 202780.00$39.3821376%60.6%$119.38$40.630
May 21, 202775.00$35.5821376%60.0%$110.58$39.430
May 21, 202770.00$31.7321376%59.8%$101.73$38.280
May 21, 202765.00$28.7021376%58.5%$93.70$36.300
May 21, 202760.00$25.8021376%57.3%$85.80$34.200
May 21, 202755.00$23.1521376%56.0%$78.15$31.850
Feb 19, 202770.00$29.3012276%55.5%$99.30$40.700
Feb 19, 202765.00$25.7312276%54.6%$90.73$39.280
Feb 19, 202760.00$22.4012276%53.8%$82.40$37.600
May 21, 202750.00$21.6521376%52.5%$71.65$28.350

As of October 21, 2026

Find the right straddle before volatility moves

Track ANAB straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial